Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Value of Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma

NCT: NCT07719634 · NOT_YET_RECRUITING

NCT IDNCT07719634
StatusNOT_YET_RECRUITING
Start Date2026-08-01
Completion2028-08-01
SponsorAssiut University (OTHER)
First posted
Last updated

Brief Summary

assess the efficacy of MWA in reducing fibroadenoma volume and achieving complete lesion regression at 12 months post-treatment

Frequently Asked Questions

What is Value of Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma?

Value of Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma is a clinical trial registered under NCT07719634. Current status: NOT_YET_RECRUITING.

What is the status of NCT07719634?

The current status of NCT07719634 (Value of Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma) is: NOT_YET_RECRUITING.

When did Value of Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma start?

Value of Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma started on 2026-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑